These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A cost-benefit analysis of prenatal diagnosis for neural tube defects selectively offered to relatives of index cases. Sadovnick AD; Baird PA Am J Med Genet; 1982 May; 12(1):63-73. PubMed ID: 6807091 [TBL] [Abstract][Full Text] [Related]
24. Studies in neural tube defects. I. Epidemiologic and etiologic aspects. Myrianthopoulos NC; Melnick M Am J Med Genet; 1987 Apr; 26(4):783-96. PubMed ID: 3296753 [TBL] [Abstract][Full Text] [Related]
25. Folic acid to prevent neural tube defects: scientific advances and public health issues. Mills JL; Conley MR Curr Opin Obstet Gynecol; 1996 Dec; 8(6):394-7. PubMed ID: 8979009 [TBL] [Abstract][Full Text] [Related]
27. Neural tube defects surveillance: a national survey. Miller LA; Kirby RS Teratology; 2000; 61(1-2):28-32. PubMed ID: 10603200 [No Abstract] [Full Text] [Related]
28. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against]. Kristoffersson U; Nørgaard-Pedersen B Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873 [No Abstract] [Full Text] [Related]
29. Pregnancies of mothers with a neural tube defect child: outcomes and recurrence risks. Swerts A; Evers-Kiebooms G; Van den Berghe H J Genet Hum; 1987 Dec; 35(5):339-49. PubMed ID: 3437264 [TBL] [Abstract][Full Text] [Related]
30. [Genetic counseling in neural tube defects; a follow-up study]. Veenema H; Ouboter-Kooij EC; van Holthe tot Echten JE Ned Tijdschr Geneeskd; 1981 Sep; 125(37):1492-6. PubMed ID: 7290222 [No Abstract] [Full Text] [Related]
31. Sacral meningocele with conotruncal heart defects: a possible autosomal recessive trait. Kousseff BG Pediatrics; 1984 Sep; 74(3):395-8. PubMed ID: 6472972 [TBL] [Abstract][Full Text] [Related]
32. A declining incidence of neural tube defects in the U.K. Laurence KM Z Kinderchir; 1989 Dec; 44 Suppl 1():51. PubMed ID: 2623962 [No Abstract] [Full Text] [Related]
33. Prevalence and prenatal diagnosis of neural tube defects in Nova Scotia in 1980-84. Winsor EJ; Brown BS CMAJ; 1986 Dec; 135(11):1269-73. PubMed ID: 3536051 [TBL] [Abstract][Full Text] [Related]
34. Update on genetic screening: an FDA approved kit, views on early diagnosis. Bermel J Hastings Cent Rep; 1983 Oct; 13(5):3-4. PubMed ID: 11644083 [TBL] [Abstract][Full Text] [Related]
35. Neural tube defects in Eastern Ontario and Western Quebec: demography and family data. Hunter AG Am J Med Genet; 1984 Sep; 19(1):45-63. PubMed ID: 6388330 [TBL] [Abstract][Full Text] [Related]
36. Maternal serum alpha-fetoprotein screening. American Public Health Association Am J Public Health; 1991 Feb; 81(2):241-2. PubMed ID: 11642861 [No Abstract] [Full Text] [Related]
37. Brief clinical report: neural tube defects as an X-linked condition. Baraitser M; Burn J Am J Med Genet; 1984 Jan; 17(1):383-5. PubMed ID: 6369986 [TBL] [Abstract][Full Text] [Related]
38. Birth prevalence and recurrence rates of neural tube defects in southern Alberta in 1970-81. Thunem NY; Lowry RB; Tucker BJ; Medd BW CMAJ; 1988 May; 138(9):819-23. PubMed ID: 3282629 [TBL] [Abstract][Full Text] [Related]
39. Recurrence risk of neural tube defects. Laurence KM J Med Genet; 1981 Aug; 18(4):322-3. PubMed ID: 7277431 [No Abstract] [Full Text] [Related]
40. Sibs of probands with neural tube defects--a study in the Federal Republic of Germany. Koch M; Fuhrmann W Hum Genet; 1985; 70(1):74-9. PubMed ID: 3873392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]